Zephyrnet Logo

Tag: internal

dWeb Foundation to Build Sub-Level Domain Naming System on Flare

[PRESS RELEASE – Singapore, SG, 16th March 2022] The dWeb Foundation has partnered with Flare Network as the next step in their journey towards building a fully-decentralized, permissionless internet built on blockchain infrastructure. The internet has become an integral part of people’s lives, an extensive web of digital data connecting people and organizations across the […]

Bexplus Offers 100x Leverage Crypto Trading & Doubles Your Deposit

To help traders earn more cryptocurrency, leading crypto derivatives exchange Bexplus has launched a 100% deposit bonus promotion to all traders. If you deposit 1 BTC, 2 BTC will be credited to your account. Every user can get up to 10 BTC for each deposit. Bitcoin‘s high volatility has made a comeback and currently presents...

The post Bexplus Offers 100x Leverage Crypto Trading & Doubles Your Deposit appeared first on Live Bitcoin News.

Google Sets The Pace In What Could Be A Record Year For Cyber M&A

Google grabbed headlines last week when it announced it will pay $5.4 billion to buy cyber firm Mandiant. While the size of the deal alone is impressive, it may also be a harbinger for a record-setting year of M&A in the space.

Best AMD motherboards in 2022

Give your build a solid foundation with our pick of the best AMD motherboards.

Fraudsters to continue exploiting supply chain woes in 2022

While supply-chain fraud is nothing new, it continues to be a major challenge globally... Read more »

The post Fraudsters to continue exploiting supply chain woes in 2022 appeared first on Logistics Business® Magazine.

Sisram Medical Ltd Announces 2021 Record Annual Results

HONG KONG, Mar 17, 2022 - (ACN Newswire) - Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more, today announced its audited consolidated annual results for the year ended December 31, 2021 (the "Reporting Period").

FINANCIAL HIGHLIGHTS
-- Revenue for the year ended December 31, 2021 was US$294.3 million, increased by 81.6% as compared to the revenue for the previous year.
-- Profit for the year ended December 31, 2021 was US$32.5 million, increased by 121.5% as compared to that for the previous year.
-- Net cash flows from operating activities for the year ended December 31, 2021 was US$32.4 million, increased by 25.8% as compared to that for the previous year.
-- Significant growth in all regions, mainly in North America and APAC. Revenue in North America for the year ended December 31, 2021 was US$112.0 million, increased by 105.8% as compared to that for the previous year. Revenue in APAC for the year ended December 31, 2021 was US$85.2 million, increased by 95.3% as compared to that for the previous year.

BUSINESS HIGHLIGHTS
-- R&D investments increased by 42.3% YoY to US$15.6 million with 2 new products launched: "Alma Duo" and "Alma PrimeX".
-- Continued the development of two new business lines - (i) Copulla - a new, innovative digital dentistry service; (ii) LMNT, a personal care brand, now launching a light-based skin rejuvenation home use device.
-- The Group entered into a sub-license agreement with Fosun Industrial for the commercialization of "RT002" Injectable, the new generation of neurotoxins for medical aesthetics use. The Group's existing injectables distribution operation, registered a revenue growth of 50.1% year over year.
-- The Group entered into an investment agreement at the amount of RMB 2.6 million for the establishment of Tianjin Xingsiyi, a research & development, technical services and supply operation for silk fibroin-sodium injectables and facial implant thread products.
-- The Group has acquired the entire share capital of Shanghai Foshion Medical System to further enhance its dental business line.
-- The Group purchased the remaining 40% equity interest in its Israeli distributor, Nova Medical. Upon completion, Nova Medical is a wholly-owned subsidiary of the Company, rebranded as Alma Israel.

FINAL DIVIDEND
-- The Board has resolved to declare a final dividend of HK$0.157 (inclusive of tax) per Share for the year ended December 31, 2021.

Business Growth Projection for 2022
Based on an increase in the demand for the Company's products and the backlog of orders as of December 31, 2021, barring any unforeseen circumstances or material change in market conditions, the Group expects to record a significant growth in revenue of over 35.0% in the first half of 2022 as compared to the revenue recorded in the corresponding period in 2021.

Record results, strong subsidiaries performance, overall geographic performance uptake, continued investments in R&D and strong business development momentum In 2021, Sisram's established global sales and distribution network recorded a total revenue of US$294.3 million for the Reporting Period, representing an increase of 81.6% when compared to 2020. All regions revenue increased substantially during the Reporting Period with North America demonstrating an increase of 105.8%, Asia Pacific with an increase of 95.3%, Latin America with an increase of 76.3%, Europe with an increase of 49.7% and Middle East & Africa with an increase of 45.2%.

The gross profit increased from US$90.3 million in 2020 to US$166.9 million in 2021, representing an increase of US$76.6 million. The gross profit margin in 2021 amounted to 56.7%, representing an increase of 1% compared to 55.7% in 2020. The establishment of direct operation offices in chosen territories has enabled the Company to shorten the supply chain, increase the average selling price, gain a higher brand visibility and ensure consistency among the communications with the target clientele. During 2021, revenue derived from direct sales has surpassed revenue derived from distributors with 62.0% attributed to the former and 38.0% to the latter.

For the Reporting Period, the Group recorded an adjusted net profit of US$40.3 million representing an increase of 100.0% when compared with the corresponding period of 2020. The adjusted net profit margin for the Reporting Period was 13.7%. The net cash flow from operating activities amounted to US$32.4 million, representing an increase of 25.8% when compared to 2020.

In 2021, Sisram continued its substantial R&D efforts, with 13% of corporate employees being R&D specialists. During the Reporting Period, R&D expense increased by 42.3% to US$15.6 million from US$11.0 million for the corresponding period in 2020. During the Reporting Period, the Group launched 2 new products, "Alma Duo" and "Alma PrimeX", as well as expanded two business lines, "Copulla" - a new, innovative digital dentistry service, and "LMNT", a personal care brand, now launching a light-based skin rejuvenation home use device.

Continued Investments in Digital Transformation and Production Ramp-up
In 2021, Sisram continued the development of its digital core architecture with vast investments in Information Systems and Digitalization, encompassing traditional ERP and CRM modules, IoT solutions for professional capital equipment, marketing automation and consumer access. Over the past 3 years (2019-2021), Sisram invested more than US$6.5 million in information systems, upgrading its ERP and CRM infrastructure, migrating to cloud-based systems to serve the entire growing and diverse eco-system and implementing new digital tools for Internal organization management, external engagement mechanisms between the organization and the market and cyber security.

On the operational front, Sisram focused on addressing the pandemic effect by investing in production ramp-up to accommodate the growing global demand and improve quality performances KPI's such as FPY (First Pass Yield) and new platforms critical failure.

A Never-before-seen Synergistic Ecosystem Composed of 4 Pillars
Sisram's Wellness Group is a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more.

As of 2021 Sisram is operating 4 business lines. The Medical Aesthetics business line, led by Alma, registered a revenue increase of 73.4%. The Injectables business line registered a revenue increase of 50.1% year over year. In 2021, Sisram integrated the activity of Shanghai Foshion Medical System into Sisram, while developing Copulla's digital dentistry service. The Personal Care business line, LMNT by Sisram Medical, is a home-use brand, immersing the essence of wellness into consumers' daily routine.

Looking forward, Mr. Liu Yi, Chairman and Executive Director of Sisram, said: "As a core member of Fosun Pharma's medical device sector, as well as the core platform of Fosun's ecosystem, we have always insisted on customer-centric philosophy and focused on technology and innovation, to continuously improve our product power and competitiveness to respond to the rapid development of the industry. In 2022, based on our charted st rategy, we will continue to promote Sisram's ecosystem, and steadily expand the product portfolio and ecological interoperability between Sisram's ecosystem, Fosun Pharma's medical device sector, and even Fosun's greater ecosystem, so as to provide customers with advanced technologies and products through the enhancement of technological applications. We will also promote the sustainable and sound development of the industry by improving clinical applications. In addition, we shall meet the market demand of the aesthetic industry through our diversified product portfolio and market strategy."

Mr. Lior Dayan, CEO of Sisram and Alma, said: "The Group's efforts during 2022 will strategically focus on expanding direct operation in strategic markets to secure market access for both professional and consumer clientele, improve digital infrastructure and tools, drive awareness and preference to our global consumer brand and leverage it to globally introduce new products and services."

About Sisram Medical Ltd
Sisram Medical Ltd (1696.HK) is a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding, ranging from medical aesthetics capital equipment, via injectables therapy, aesthetic dentistry, personal care and more. The company is majority held by Fosun Pharma, a leading healthcare group in China. Sisram Medical successfully went public on September 19, 2017, as the first Israeli company listed on the Hong Kong Exchange Main Board.

Sisram Medical - Enhancing Quality of Life
http://www.sisram-medical.com


Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comSisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the "Group"), a global consumer wellness group, featuring a never-before-seen synergistic ecosystem of business building blocks and consumer-focused branding

ACLU of Missouri backs marijuana legalization, expungement campaign; critics slam the endorsement – Newstalk KZRG

The ACLU of Missouri is the latest legal organization to endorse Legal Missouri 2022, the citizens’ ballot initiative that ties ... Read More

This Cyber Tool Can Allow You to Message Anyone From Anywhere

People worldwide have sent emails and text messages straight to Russian citizens via 1920.in, a cyber tool to workaround Russia’s internet blockade (1). Polish programmers created the website after acquiring 20 million phone numbers and nearly 140 million emails from Russian individuals and businesses. The site generates numbers and addresses at random from those records. It […]

When is the Coinbase NFT Marketplace Launching?

The world’s leading cryptocurrency exchange Coinbase has announced its entry into the NFT space with the upcoming launch of an NFT marketplace, promising to bring more surprise to the sector. The initial post made by Coinbase NFT, the official Twitter account of the incoming NFT marketplace, revealed that the team behind this new platform was [...]

The post When is the Coinbase NFT Marketplace Launching? appeared first on Blockonomi.

Litecoin (LTC) Price Analysis: Bulls Aim Key Upside Break

Litecoin is eyeing an upside break above the $115 resistance against the US Dollar. LTC price is now trading above $100 and the 55 simple moving average (4-hours). There is a key bullish trend line forming with support near $106 on the 4-hours chart of the LTC/USD pair (data feed from Coinbase). The pair could...

The post Litecoin (LTC) Price Analysis: Bulls Aim Key Upside Break appeared first on Live Bitcoin News.

Pax Celebrates the Unsung Heroines of Cannabis

@TLStanleyLA terry.stanley@adweek.com T.L. Stanley is a senior editor at Adweek, where she specializes in consumer trends, cannabis marketing, plant-based food ... Read More

Rihanna Files Application To Offer Products In The Metaverse

Rihanna conquered the physical world, is popular in the Web 2.0, and now wants to conquer the Web 3.0, making a name in the metaverse.

Latest Intelligence

spot_img
spot_img